Cyclic Peptides as Therapeutic Agents and Biochemical Tools

  • Joo, Sang-Hoon (Laboratory of Biochemistry, College of Pharmacy, Catholic University of Daegu)
  • Received : 2011.09.02
  • Accepted : 2011.10.28
  • Published : 2012.01.31


There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. Encouraged by natural cyclic peptides with biological activity, efforts have been made to develop cyclic peptides with both genetic and synthetic methods. The genetic methods include phage display, intein-based cyclic peptides, and mRNA display. The synthetic methods involve individual synthesis, parallel synthesis, as well as split-and-pool synthesis. Recent development of cyclic peptide library based on split-and-pool synthesis allows on-bead screening, in-solution screening, and microarray screening of cyclic peptides for biological activity. Cyclic peptides will be useful as receptor agonist/antagonist, RNA binding molecule, enzyme inhibitor and so on, and more cyclic peptides will emerge as therapeutic agents and biochemical tools.


  1. Athanassiou, Z., Dias, R. L., Moehle, K., Dobson, N., Varani, G. and Robinson, J. A. (2004) Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affi nity and selectivity for viral TAR RNA regulatory elements. J. Am. Chem. Soc. 126, 6906-6913.
  2. Athanassiou, Z., Patora, K., Dias, R. L., Moehle, K., Robinson, J. A. and Varani, G. (2007) Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodefi ciency virus. Biochemistry. 46, 741-751.
  3. Bu, X., Wu, X., Xie, G. and Guo, Z. (2002) Synthesis of tyrocidine A and its analogues by spontaneous cyclization in aqueous solution. Org. Lett. 4, 2893-2895.
  4. Colgrave, M. L., Korsinczky, M. J., Clark, R. J., Foley, F. and Craik, D. J. (2010) Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. Biopolymers. 94, 665-672.
  5. Dubos, R. J. and Cattaneo, C. (1939) Studies on a bactericidal agent extracted from a soil bacillus : Iii. preparation and activity of a protein-free fraction. J. Exp. Med. 70, 249-256.
  6. Eckert, K., Schwarz, H., Tomer, K. B. and Gross, M. L. (1985). Tandem mass spectrometry methodology for the sequence determination of cyclic peptides. J. Am. Chem. Soc. 107, 6765-6769.
  7. Edman, P. (1959) Chemistry of amino acids and peptides. Annu. Rev. Biochem. 28, 69-96.
  8. Furka, A., Sebestyen, F., Asgedom, M. and Dibo, G. (1991) General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein. Res. 37, 487-493.
  9. Gehlsen, K. R., Argraves, W. S., Pierschbacher, M. D. and Ruoslahti, E. (1988) Inhibition of in vitro tumor cell invasion by Arg-Gly-Aspcontaining synthetic peptides. J. Cell. Biol. 106, 925-930.
  10. Giroux, R. (2005) Cyclosporine. Chem. Eng. News. 83, 56.
  11. Gurrath, M., Müller, G., Kessler, H., Aumailley, M. and Timpl, R. (1992) Conformation/activity studies of rationally designed potent antiadhesive RGD peptides. Eur. J. Biochem. 210, 911-921.
  12. Hayashi, R., Tanoue, K., Durell, S. R., Chatterjee, D. K., Jenkins, L. M., Appella, D. H. and Appella, E. (2011) Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry. 50, 4537-4549.
  13. Hayouka, Z., Hurevich, M., Levin, A., Benyamini, H., Iosub, A., Maes, M., Shalev, D. E., Loyter, A., Gilon, C. and Friedler, A. (2010) Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorg. Med. Chem. 18, 8388-8395.
  14. Hodgkin, D. C. and Oughton, B. M. (1957) Possible molecular models for gramicidin S and their relationship to present ideas of protein structure. Biochem. J. 65, 752-756.
  15. Horswill, A. R., Savinov, S. N. and Benkovic, S. J. (2004) A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 101, 15591-15596.
  16. Horton, D. A., Bourne, G. T. and Smythe, M. L. (2002) Exploring privileged structures: the combinatorial synthesis of cyclic peptides. J. Comput. Aided. Mol. Des. 16, 415-430.
  17. Hotchkiss, R. D. (1941) The chemical nature of gramicidin and tyrocidine. J. Biol. Chem. 141, 171-185.
  18. Hotchkiss, R. D. and Dubos, R. J. (1941) The isolation of bactericidal substances from cultures of Bacillus brevis. J. Biol. Chem. 141, 155-162.
  19. Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T. and Cuervo, J. H. (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature. 354, 84-86.
  20. Hull, S. E., Karlsson, R., Main, P., Woolfson, M. M. and Dodson, E. J. (1978) The crystal structure of a hydrated gramicidin S-urea complex. Nature. 275, 206-207.
  21. Hummel, G., Reineke, U. and Reimer, U. (2006) Translating peptides into small molecules. Mol. Biosyst. 2, 499-508.
  22. Humphries, M. J., Olden, K. and Yamada, K. M. (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 233, 467-470.
  23. Joo, S. H., Xiao, Q., Ling, Y., Gopishetty, B. and Pei, D. (2006) Highthroughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry. J. Am. Chem. Soc. 128, 13000-13009.
  24. Kohli, R. M., Walsh, C. T. and Burkart, M. D. (2002) Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418, 658-661.
  25. Koivunen, E., Gay, D. A. and Ruoslahti, E. (1993) Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem. 268, 20205-20210.
  26. Kwon, Y. U. and Kodadek, T. (2007) Quantitative comparison of the relative cell permeability of cyclic and linear peptides. Chem. Biol. 14, 671-677.
  27. Kwon, Y. U. and Kodadek, T. (2008) Encoded combinatorial libraries for the construction of cyclic peptoid microarrays. Chem. Commun. (Camb). 44, 5704-5706.
  28. Lalonde, M. S., Lobritz, M. A., Ratcliff, A., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J., Robinson, J. A., Karn, J., Varani, G. and Arts, E. J. (2011) Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tattransactivating response element (TAR) RNA. PLoS. Pathog. 7, e1002038.
  29. Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M. and Knapp, R. J. (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 354, 82-84.
  30. Liu, T., Joo, S. H., Voorhees, J. L., Brooks, C. L. and Pei, D. (2009) Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg. Med. Chem. 17, 1026-1033.
  31. Liu, T., Liu, Y., Kao, H. Y. and Pei, D. (2010) Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1. J. Med. Chem. 53, 2494-2501.
  32. Loffet, A. (2002) Peptides as drugs: is there a market? J. Pept. Sci. 8, 1-7.
  33. Mas-Moruno, C., Rechenmacher, F. and Kessler, H. (2010) Cilengitide: the fi rst anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer. Agents. Med. Chem. 10, 753-768.
  34. Matsuzaki, K. (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462, 1-10.
  35. Millward, S. W., Fiacco, S., Austin, R. J. and Roberts, R. W. (2007) Design of cyclic peptides that bind protein surfaces with antibody-like affi nity. ACS. Chem. Biol. 2, 625-634.
  36. Millward, S. W., Takahashi, T. T. and Roberts, R. W. (2005) A general route for post-translational cyclization of mRNA display libraries. J. Am. Chem. Soc. 127, 14142-14143.
  37. Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W. and Cheresh, D. A. (2008) Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl. Acad. Sci. USA 105, 9343-9348.
  38. Naumann, T. A., Tavassoli, A. and Benkovic, S. J. (2008) Genetic selection of cyclic peptide Dam methyltransferase inhibitors. Chembiochem. 9, 194-197.
  39. Ngoka, L. C. and Gross, M. L. (1999) Multistep tandem mass spectrometry for sequencing cyclic peptides in an ion-trap mass spectrometer. J. Am. Soc. Mass. Spectrom. 10, 732-746.
  40. Noiri, E., Gailit, J., Sheth, D., Magazine, H., Gurrath, M., Muller, G., Kessler, H. and Goligorsky, M. S. (1994) Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney. Int. 46, 1050-1058.
  41. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A. and DeGrado, W. F. (1992) Identifi cation of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins. 14, 509-515.
  42. Park, B. W., Zhang, H. T., Wu, C., Berezov, A., Zhang, X., Dua, R., Wang, Q., Kao, G., O'Rourke, D. M., Greene, M. I. and Murali, R. (2000) Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nat. Biotechnol. 18, 194-198.
  43. Perler, F. B. (2005) Protein splicing mechanisms and applications. IUBMB. Life. 57, 469-476.
  44. Perler, F. B, Davis, E. O., Dean, G. E., Gimble, F. S., Jack, W. E., Neff, N., Noren, C. J., Thorner, J. and Belfort, M. (1994) Protein splicing elements: inteins and exteins--a defi nition of terms and recommended nomenclature. Nucleic. Acids. Res. 22, 1125-1127.
  45. Qin, C., Bu, X., Zhong, X., Ng, N. L. and Guo, Z. (2004) Optimization of antibacterial cyclic decapeptides. J. Comb. Chem. 6, 398-406.
  46. Qin, C., Zhong, X., Bu, X., Ng, N. L. and Guo, Z. (2003) Dissociation of antibacterial and hemolytic activities of an amphipathic peptide antibiotic. J. Med. Chem. 46, 4830-4833.
  47. Redman, J. E., Wilcoxen, K. M. and Ghadiri, M. R. (2003) Automated mass spectrometric sequence determination of cyclic peptide library members. J. Comb. Chem. 5, 33-40.
  48. Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P. and Lokey, R. S. (2006) Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J. Am. Chem. Soc. 128, 2510-2511.
  49. Roberts, R. W. and Szostak, J. W. (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 94, 12297-12302.
  50. Schilling, B., Wang, W., McMurray, J.S. and Medzihradszky, K.F. (1999) Fragmentation and sequencing of cyclic peptides by matrixassisted laser desorption/ionization post-source decay mass spectrometry. Rapid. Commun. Mass. Spectrom. 13, 2174-2179.<2174::AID-RCM771>3.0.CO;2-K
  51. Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C. and Benkovic, S. J. (1999) Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. USA 96, 13638-13643.
  52. Siegel, M. M., Huang, J., Lin, B., Tsao, R. and Edmonds, C. G. (1994) Structures of bacitracin A and isolated congeners: sequencing of cyclic peptides with blocked linear side chains by electrospray ionization mass spectrometry. Biol. Mass. Spectrom. 23, 186-204.
  53. Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228, 1315-1317.
  54. Stauch, B., Simon, B., Basile, T., Schneider, G., Malek, N. P., Kalesse, M. and Carlomagno, T. (2010) Elucidation of the structure and intermolecular interactions of a reversible cyclic-peptide inhibitor of the proteasome by NMR spectroscopy and molecular modeling. Angew. Chem. Int. Ed. Engl. 49, 3934-3938.
  55. Sweeney, M. C. and Pei, D. (2003) An improved method for rapid sequencing of support-bound peptides by partial edman degradation and mass spectrometry. J. Comb. Chem. 5, 218-222.
  56. Synge, R. L. (1945) 'Gramicidin S': over-all chemical characteristics and amino-acid composition. Biochem. J. 39, 363-367.
  57. Tamamura, H., Tsutsumi, H., Masuno, H., Mizokami, S., Hiramatsu, K., Wang, Z., Trent, J. O., Nakashima, H., Yamamoto, N., Peiper, S. C. and Fujii, N. (2006) Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. Org. Biomol. Chem. 4, 2354-2357.
  58. Tamamura, H., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., Nakashima, H. and Fujii, N. (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem. Biophys. Res. Commun. 253, 877-882.
  59. Tavassoli. A., Benkovic, S. J. (2005) Genetically selected cyclic-peptide inhibitors of AICAR transformylase homodimerization. Angew. Chem. Int. Ed. Engl. 44, 2760-2763.
  60. Tavassoli, A., Lu, Q., Gam, J., Pan, H., Benkovic, S. J. and Cohen, S. N. (2008) Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS. Chem. Biol. 3, 757-764.
  61. Thakkar. A., Wavreille. A.S. and Pei, D. (2006) Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry. Anal. Chem. 78, 5935-5939.
  62. Vlieghe, P., Lisowski, V., Martinez, J. and Khrestchatisky, M. (2010) Synthetic therapeutic peptides: science and market. Drug. Discov. Today. 15, 40-56.
  63. Wenger, R. M. (1984) Synthesis of cycosporine. Total syntheses of 'cyclosporin A' and 'cyclosporin H', two fungal metabolites isolated from the species. Tolypocladium infl atum GAMS. Helvetica. Chimica. Acta. 67, 502-525.
  64. Xiao, Q. and Pei, D. (2007) High-throughput synthesis and screening of cyclic peptide antibiotics. J. Med. Chem. 50, 3132-3137.
  65. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature. 415, 389-395.

Cited by

  1. Design of Cyclic Peptide Based Glucose Receptors and Their Application in Glucose Sensing 2017,
  2. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections vol.11, pp.7, 2016,
  3. Cyclic peptides identified by phage display are competitive inhibitors of the tRNA-dependent amidotransferase of Helicobacter pylori vol.79, 2016,
  4. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1 vol.26, pp.12, 2016,
  5. Peptides for tumor-specific drug targeting: state of the art and beyond vol.5, pp.23, 2017,
  6. Anticancer compounds from cyanobacterium Lyngbya species: a review vol.108, pp.2, 2015,
  7. Peptide Macrocycles Featuring a Backbone Secondary Amine: A Convenient Strategy for the Synthesis of Lipidated Cyclic and Bicyclic Peptides on Solid Support vol.17, pp.10, 2015,
  8. Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity vol.11, pp.18, 2016,
  9. Pyrrolysine-Inspired Protein Cyclization vol.15, pp.12, 2014,
  10. Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics vol.55, pp.19, 2016,
  11. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis vol.74, 2017,
  12. Solid-phase synthesis, cyclization, and site-specific functionalization of aziridine-containing tetrapeptides vol.12, pp.6, 2017,
  13. Total Synthesis and Pharmacological Investigation of Cordyheptapeptide A vol.22, pp.6, 2017,
  14. Review cyclic peptides on a merry-go-round; towards drug design vol.104, pp.5, 2015,
  15. Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy ofd-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species vol.7, pp.8, 2016,
  16. Structure and Antibacterial Activity of Ambobactin, a New Telomycin-Like Cyclic Depsipeptide Antibiotic Produced by Streptomyces ambofaciens F3 vol.20, pp.9, 2015,
  17. Characterization of the Free State Ensemble of the CoRNR Box Motif by Molecular Dynamics Simulations vol.120, pp.6, 2016,
  18. Fine-Tuning the Balance between Peptide Thioester Cyclization and Racemization vol.2016, pp.3, 2016,
  19. “Freeze, Don’t Move”: How to Arrest a Suspect in Heart Failure – A Review on Available GRK2 Inhibitors vol.3, 2016,
  20. Structural analyses of isolated cyclic tetrapeptides with varying amino acid residues vol.19, pp.17, 2017,
  21. Triazene as a Powerful Tool for Solid-Phase Derivatization of Phenylalanine Containing Peptides: Zygosporamide Analogues as a Proof of Concept vol.79, pp.23, 2014,
  22. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging vol.27, pp.12, 2017,
  23. Antifungal activityin vitroandin vivoof a salmon protamine peptide and its derived cyclic peptide againstCandida albicans vol.17, pp.1, 2017,
  24. Synthetic strategy for bicyclic tetrapeptides HDAC inhibitors using ring closing metathesis vol.127, pp.9, 2015,
  25. Re-evaluation of the N-terminal substitution and the D-residues of teixobactin vol.6, pp.77, 2016,
  26. Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide-Heterocycle Scaffolds vol.2016, pp.19, 2016,
  27. Phage Selection of Cyclic Peptides for Application in Research and Drug Development vol.50, pp.8, 2017,
  28. Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties vol.23, pp.2, 2015,
  29. Scalable synthesis of the unusual amino acid segment (ADMOA unit) of marine anti-inflammatory peptide: solomonamide A vol.13, pp.22, 2015,
  30. Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization vol.6, pp.1, 2017,
  31. Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics vol.128, pp.19, 2016,
  32. Peptide 2-formylthiophenol esters do not proceed through a Ser/Thr ligation pathway, but participate in a peptide aminolysis to enable peptide condensation and cyclization vol.13, pp.25, 2015,
  33. Emerging biopharmaceuticals from bioactive peptides derived from marine organisms vol.90, pp.1, 2017,
  34. Oral Administration of Peptide-Based Drugs: Beyond Lipinski's Rule vol.11, pp.20, 2016,
  35. Virtual screening of commercial cyclic peptides as NS2B-NS3 protease inhibitor of dengue virus serotype 2 through molecular docking simulation vol.188, 2017,
  36. A Threshold-Minimization Scheme for Exploring the Energy Landscape of Biomolecules: Application to a Cyclic Peptide and a Disaccharide vol.12, pp.5, 2016,
  37. Antimicrobial Cyclic Peptides for Plant Disease Control vol.31, pp.1, 2015,
  38. Characterization of bacterial antimicrobial peptides active againstCampylobacter jejuni vol.93, pp.4, 2015,
  39. Incrementally increasing the length of a peptide backbone: effect on macrocyclisation efficiency vol.12, pp.26, 2014,
  40. Ring Closing and Macrocyclization of β-Dipeptides by Olefin Metathesis vol.2013, pp.28, 2013,
  41. Selective Phosphorylation Inhibitor of Delta Protein Kinase C–Pyruvate Dehydrogenase Kinase Protein–Protein Interactions: Application for Myocardial Injuryin Vivo vol.138, pp.24, 2016,
  42. Aziridine-Mediated Ligation at Phenylalanine and Tryptophan Sites vol.12, pp.15, 2017,
  43. Accurate Structure Prediction and Conformational Analysis of Cyclic Peptides with Residue-Specific Force Fields vol.7, pp.10, 2016,
  44. Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential vol.38, pp.5, 2017,
  45. Peptide Synthesis Utilizing Micro-flow Technology pp.18614728, 2018,
  46. -methylation in amino acids and peptides: Scope and limitations vol.109, pp.10, 2018,
  47. Application of HPCCC Combined with Polymeric Resins and HPLC for the Separation of Cyclic Lipopeptides Muscotoxins A–C and Their Antimicrobial Activity vol.23, pp.10, 2018,
  48. A Tetra-Orthogonal Strategy for the Efficient Synthesis of Scaffolds Based on Cyclic Peptides vol.24, pp.4, 2018,
  49. to novel approaches for overcoming antibiotic resistance pp.02724391, 2018,
  50. Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review vol.23, pp.8, 2018,
  51. Quantification of intramolecular click chemistry modified synthetic peptide isomers in mixtures using tandem mass spectrometry and the survival yield technique vol.410, pp.23, 2018,
  52. Recent Reports of Solid-Phase Cyclohexapeptide Synthesis and Applications vol.23, pp.6, 2018,
  53. Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88 vol.8, pp.1, 2018,
  54. Chemical Synthesis and Functional Analysis of VarvA Cyclotide vol.23, pp.4, 2018,
  55. Synthesis and anticancer activities of proline-containing cyclic peptides and their linear analogs and congeners vol.49, pp.2, 2019,